Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Haemolytic uraemic syndrome following bone marrow transplantation Case report and review of the literature Verburgh CA; Vermeij CG; Zijlmans JM; van Veen S; van Es LANephrol Dial Transplant 1996[Jul]; 11 (7): 1332-7Thrombotic microangiopathy (TMA) can be a late complication of bone marrow transplantation (BMT). A patient is described in whom the haemolytic uraemic syndrome developed 10 months after BMT and who died of E. coli sepsis while on maintenance haemodialysis. The literature is reviewed, regarding clinical presentation, incidence, pathogenesis and therapy. TMA can be observed, after an interval of 3-12 months, in about 6-26% of patients following BMT. Reported cases vary considerably in clinical severity, from mild presentations to severe TMA with high mortality rates despite intensive therapy. Important pathogenetic roles are ascribed to the conditioning total body irradiation and the use of cyclosporin A, but other factors may be involved as well. Next to supportive therapy, plasma exchange and the use of ACE inhibitors may be of value in treating BMT-associated TMA.|Bone Marrow Transplantation/*adverse effects[MESH]|Cyclosporine/adverse effects[MESH]|Escherichia coli Infections/complications[MESH]|Female[MESH]|Hemolytic-Uremic Syndrome/complications/*etiology/therapy[MESH]|Humans[MESH]|Middle Aged[MESH]|Sepsis/complications[MESH]|Thrombosis/complications/etiology[MESH]|Whole-Body Irradiation/adverse effects[MESH] |